Aditya Sheth
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Aditya Sheth has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Amber L. Smith
Department of Cell and Molecular Biology, St. Jude Children’s Research Hospital, Memphis, TN, USA
1 shared publication Christopher W. Wright
Department of Cell and Molecular Biology, St. Jude Children’s Research Hospital, Memphis, TN, USA
1 shared publication- Gautam Pareek
Department of Cell and Molecular Biology, St. Jude Children’s Research Hospital, Memphis, TN, USA
1 shared publication - Geoffrey Neale
Hartwell Center, St. Jude Children’s Research Hospital, Memphis, USA
1 shared publication - Hailey S. Ross
Department of Cell and Molecular Biology, St. Jude Children’s Research Hospital, Memphis, TN, USA
1 shared publication - Huiyun Wu
Department of Biostatistics, St. Jude Children’s Research Hospital, Memphis, TN, USA
1 shared publication
Latest Publications
- Open Access
- 3 January 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (1) , eads8489
Somatic mtDNA mutation burden shapes metabolic plasticity in leukemogenesis
The role of somatic mitochondrial DNA (mtDNA) mutations in leukemogenesis remains poorly characterized. To determine the impact of somatic mtDNA mutations on this process, we assessed the leukemogenic potential of hematopoietic progenitor cells (HPCs) from mtDNA mutator mice (Polg D257A) with or without NMyc overexpression. We observed a higher incidence of spontaneous leukemogenesis in recipients transplanted with heterozygous Polg HPCs and a lower incidence of NMyc-driven leukemia in those with homozygous Polg HPCs compared to controls. Although mtDNA mutations in heterozygous and homozygous HPCs caused similar baseline impairments in mitochondrial function, only heterozygous HPCs responded to and supported altered metabolic demands associated with NMyc overexpression. Homozygous HPCs showed altered glucose utilization with pyruvate dehydrogenase inhibition due to increased phosphorylation, exacerbated by NMyc overexpression. The impaired growth of NMyc-expressing homozygous HPCs was partially rescued by inhibiting pyruvate dehydrogenase kinase, highlighting a relationship between mtDNA mutation burden and metabolic plasticity in leukemogenesis.
- 3 January 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (1) , eads8489
Open AccessSomatic mtDNA mutation burden shapes metabolic plasticity in leukemogenesis
The role of somatic mitochondrial DNA (mtDNA) mutations in leukemogenesis remains poorly characterized. To determine the impact of somatic mtDNA mutations on this process, we assessed the leukemogenic potential of hematopoietic progenitor cells (HPCs) from mtDNA mutator mice (Polg D257A) with or without NMyc overexpression. We observed a higher incidence of spontaneous leukemogenesis in recipients transplanted with heterozygous Polg HPCs and a lower incidence of NMyc-driven leukemia in those with homozygous Polg HPCs compared to controls. Although mtDNA mutations in heterozygous and homozygous HPCs caused similar baseline impairments in mitochondrial function, only heterozygous HPCs responded to and supported altered metabolic demands associated with NMyc overexpression. Homozygous HPCs showed altered glucose utilization with pyruvate dehydrogenase inhibition due to increased phosphorylation, exacerbated by NMyc overexpression. The impaired growth of NMyc-expressing homozygous HPCs was partially rescued by inhibiting pyruvate dehydrogenase kinase, highlighting a relationship between mtDNA mutation burden and metabolic plasticity in leukemogenesis.